Birdwatch Note
2024-08-01 15:26:09 UTC - NOT_MISLEADING
Imane Khalid é cisgenero e possui distúrbio do desenvolvimento sexual (DDS). A atleta é da Argélia, país que proíbe tratamentos hormonais para pessoas transgenero. https://en.m.wikipedia.org/wiki/Imane_Khelif
Written by E54554513803816E249E0163E8ABAFC2D5AA3F6F2BC488E88F1162E34B601592
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819010137727631524
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819031873407811773
- noteId - 1819031873407811773
- participantId -
- noteAuthorParticipantId - E54554513803816E249E0163E8ABAFC2D5AA3F6F2BC488E88F1162E34B601592 Participant Details
- createdAtMillis - 1722525969255
- tweetId - 1819010137727631524
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Imane Khalid é cisgenero e possui distúrbio do desenvolvimento sexual (DDS). A atleta é da Argélia, país que proíbe tratamentos hormonais para pessoas transgenero. https://en.m.wikipedia.org/wiki/Imane_Khelif
Note Ratings
| rated at | rated by | |
| 2024-08-02 07:35:52 -0500 | Rating Details | |
| 2024-08-01 17:14:24 -0500 | Rating Details | |
| 2024-08-01 16:52:31 -0500 | Rating Details | |
| 2024-08-01 16:09:58 -0500 | Rating Details | |
| 2024-08-01 14:53:44 -0500 | Rating Details | |
| 2024-08-01 14:52:31 -0500 | Rating Details | |
| 2024-08-01 14:48:02 -0500 | Rating Details | |
| 2024-08-01 14:29:02 -0500 | Rating Details | |
| 2024-08-01 14:14:09 -0500 | Rating Details | |
| 2024-08-01 13:43:52 -0500 | Rating Details | |
| 2024-08-01 13:34:03 -0500 | Rating Details | |
| 2024-08-01 13:15:32 -0500 | Rating Details | |
| 2024-08-01 13:15:09 -0500 | Rating Details | |
| 2024-08-01 12:56:58 -0500 | Rating Details | |
| 2024-08-01 12:15:10 -0500 | Rating Details | |
| 2024-08-01 12:13:50 -0500 | Rating Details | |
| 2024-08-01 11:38:17 -0500 | Rating Details | |
| 2024-08-01 11:28:49 -0500 | Rating Details | |
| 2024-08-01 11:19:12 -0500 | Rating Details | |
| 2024-08-01 11:17:29 -0500 | Rating Details | |
| 2024-08-01 11:11:19 -0500 | Rating Details | |
| 2024-08-01 11:06:01 -0500 | Rating Details | |
| 2024-08-01 11:03:42 -0500 | Rating Details | |
| 2024-08-01 11:00:51 -0500 | Rating Details | |
| 2024-08-01 10:56:32 -0500 | Rating Details | |
| 2024-08-01 10:51:13 -0500 | Rating Details | |
| 2024-08-01 10:45:07 -0500 | Rating Details | |
| 2024-08-01 10:39:54 -0500 | Rating Details | |
| 2024-08-01 10:36:10 -0500 | Rating Details | |
| 2024-08-02 22:14:40 -0500 | Rating Details | |
| 2024-08-01 22:50:22 -0500 | Rating Details |